Covermymeds Pharmacy LLC

Covermymeds Pharmacy LLC, a for-profit pharmaceutical supplier based in Memphis, Tennessee, delivers specialty oncology medications and institutional pharmacy services to federal healthcare facilities as a prime contractor in full-and-open procurements without set-aside protection. The vendor holds no SBA certifications and competes across all awards as a noncompetitive vendor to federal medical facilities and correctional institutions.

Covermymeds' federal footprint is narrowly concentrated in pharmaceutical supply to the Department of Veterans Affairs and the Department of Justice. Veterans Integrated Service Network 2 (VA Brooklyn facility and outlying VISN 2 network operations) represents 76% of recent award count with 13 orders totaling $208 thousand and focusing on Pomalyst (pomalidomide), Revlimid (lenalidomide), and related immunomodulatory agents used in hematologic malignancy treatment. The remaining 24% of orders split between the Federal Correctional Complex Butner, which awarded a $340 thousand specialty medication purchase order (February 1 through September 30, 2026), Federal Medical Center Lexington with two $22.6 thousand non-contract specialty medication orders, and Veterans Integrated Service Network 8 with a single order. The dollar ranking inverts the volume ranking: Butner's single large order represents 57% of combined potential value, while VISN 2's thirteen smaller orders represent 35%.

All 17 awards are purchase orders with firm fixed-price terms and no set-aside designation, indicating full-and-open competitive or direct-to-vendor procurement. Average order value is approximately $34.9 thousand, with individual VISN 2 orders clustering around $16.3 thousand to $16.4 thousand (standard Pomalyst capsule requisitions) and emergency procurements carrying identical ceiling values. Performance occurs predominantly in Memphis, Tennessee, with some orders specifying Brooklyn, New York as the place of performance. The source data covers a single calendar year (January 16 through September 24, 2026), representing 17 awards with combined obligated value of $593 thousand. Only one award faces ultimate completion within the next twenty-four months and recompete exposure. Covermymeds holds no position on government-wide acquisition contracts, blanket purchase agreements, or indefinite-delivery vehicles; all awards are transactional purchase orders issued directly by individual VA networks and Bureau of Prisons facilities. The vendor operates exclusively as a prime and carries no subcontract relationships in the source data.